- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
该股进入多头行情中，股价短线上涨概率较大。
- 中期趋势：
正处于反弹阶段。
- 长期趋势：
已有199家主力机构披露2025-06-30报告期持股数据，持仓量总计4.87亿股，占流通A股50.61%
- 波段诊断：
-
技术面诊股
诊断结果：6.4技术面打败了59%的股票
技术面评分前10的股票
近期的平均成本为13.84元。空头行情中，目前正处于反弹阶段，投资者可适当关注。
平均成本
近期的平均成本为13.84元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"13.84","date":1767083938,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势接近大盘，跑赢行业平均水平。
[{"date":"2025.12.31","stock":"0.87","trade":"-0.07","ind":"0.09"},{"date":"2025.12.30","stock":"0.00","trade":"-0.48","ind":"-0.00"},{"date":"2025.12.29","stock":"-0.65","trade":"-1.13","ind":"0.04"},{"date":"2025.12.26","stock":"-0.14","trade":"-0.41","ind":"0.10"},{"date":"2025.12.25","stock":"0.00","trade":"0.35","ind":"0.47"},{"date":"2025.12.24","stock":"-0.36","trade":"0.28","ind":"0.53"},{"date":"2025.12.23","stock":"-0.43","trade":"-0.30","ind":"0.07"},{"date":"2025.12.22","stock":"0.07","trade":"0.14","ind":"0.69"},{"date":"2025.12.19","stock":"1.38","trade":"1.80","ind":"0.36"},{"date":"2025.12.18","stock":"0.58","trade":"0.51","ind":"0.16"},{"date":"2025.12.17","stock":"0.88","trade":"0.69","ind":"1.19"},{"date":"2025.12.16","stock":"-1.88","trade":"-2.00","ind":"-1.11"},{"date":"2025.12.15","stock":"-0.29","trade":"-1.10","ind":"-0.55"},{"date":"2025.12.12","stock":"0.14","trade":"-0.50","ind":"0.41"},{"date":"2025.12.11","stock":"-0.57","trade":"-0.87","ind":"-0.70"},{"date":"2025.12.10","stock":"0.43","trade":"-0.07","ind":"-0.23"},{"date":"2025.12.09","stock":"-0.72","trade":"-1.51","ind":"-0.37"},{"date":"2025.12.08","stock":"-0.43","trade":"0.25","ind":"0.54"},{"date":"2025.12.05","stock":"0.65","trade":"0.10","ind":"0.70"},{"date":"2025.12.04","stock":"-0.50","trade":"-0.40","ind":"-0.06"},{"date":"2025.12.03","stock":"-0.07","trade":"-0.45","ind":"-0.51"}]
浙江医药,上证指数,化学制药指数
压力支撑
该股压力位为13.81元，支撑位为13.64元。
[{"text":"\u538b\u529b\u4f4d","value":"13.81","date":1767110400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"13.64","date":1767110400,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前正处于反弹阶段，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.3资金面打败了27%的股票
主力控盘前10的股票
行业资金
化学制药行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：01月02日 20:31
| 机构今日流向(万元) | -868.12 | 机构5日流向(万元) | -4999.06 |
| 机构10日流向(万元) | -4506.97 | 机构20日流向(万元) | -12203.95 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量减少1484.92万股，其中基金净减仓37家，主力净减仓158家，请投资者中长期谨慎为宜。
截止2025-06-30，共199家主力机构（基金195家，一般法人4家），持仓量总计48664.44万股，占流通A股50.61%
其中，基金持仓与2024-12-31相比：
增仓：39家 ，增持 453.93万股
减仓：76家 ，减持 902.21万股
新出现在主力名单中：74家 ，持有673.3万股
从主力名单中消失：232家 ，原持有4310.11万股
其中，基金持仓与2024-12-31相比：
增仓：39家 ，增持 453.93万股
减仓：76家 ，减持 902.21万股
新出现在主力名单中：74家 ，持有673.3万股
从主力名单中消失：232家 ，原持有4310.11万股
消息面诊股
诊断结果：5.5消息面打败了58%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 浙江医药：12月30日获融资买入760.41万元
2025-12-31 - 浙江医药：12月29日获融资买入1504.48万元
2025-12-30 - 券商观点|基础化工行业周报：11月TDI出口量创单
2025-12-29 - 浙江医药：12月26日获融资买入1699.58万元
2025-12-27 - 浙江医药：12月25日获融资买入1016.00万元
2025-12-26 - 浙江医药：12月24日获融资买入959.86万元
2025-12-25 - 浙江医药：12月19日获融资买入644.96万元
2025-12-20 - 存量竞争加剧，医药商业行业并购潮涌，集中度提升成长
2025-12-18 - 浙江医药：12月17日获融资买入975.69万元
2025-12-18 - 浙江医药：12月16日获融资买入1015.82万元
2025-12-17
消息列表
| 一般消息 | 股东大会 | 临时股东大会 | 2025-10-28 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-26 |
| 重大利好 | 业绩预告 | 业绩大幅上升 | 2025-07-15 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-06-25 |
| 利好 | 分红转增 | 10派3.7元(含税) | 2025-04-24 |
| 重大利好 | 业绩预告 | 业绩大幅上升 | 2025-01-23 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 3条 | 2条 | 1条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：6.2行业面打败了76%的股票
化学制药行业最新资金流向
近10日来该行业走势不明显，跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，跑输大盘。
[{"date":"2025.12.31","price":"0.09","value":"-0.07"},{"date":"2025.12.30","price":"-0.00","value":"-0.48"},{"date":"2025.12.29","price":"0.04","value":"-1.13"},{"date":"2025.12.26","price":"0.10","value":"-0.41"},{"date":"2025.12.25","price":"0.47","value":"0.35"},{"date":"2025.12.24","price":"0.53","value":"0.28"},{"date":"2025.12.23","price":"0.07","value":"-0.30"},{"date":"2025.12.22","price":"0.69","value":"0.14"},{"date":"2025.12.19","price":"0.36","value":"1.80"},{"date":"2025.12.18","price":"0.16","value":"0.51"},{"date":"2025.12.17","price":"1.19","value":"0.69"},{"date":"2025.12.16","price":"-1.11","value":"-2.00"},{"date":"2025.12.15","price":"-0.55","value":"-1.10"},{"date":"2025.12.12","price":"0.41","value":"-0.50"},{"date":"2025.12.11","price":"-0.70","value":"-0.87"},{"date":"2025.12.10","price":"-0.23","value":"-0.07"},{"date":"2025.12.09","price":"-0.37","value":"-1.51"},{"date":"2025.12.08","price":"0.54","value":"0.25"},{"date":"2025.12.05","price":"0.70","value":"0.10"},{"date":"2025.12.04","price":"-0.06","value":"-0.40"},{"date":"2025.12.03","price":"-0.51","value":"-0.45"}]
上证指数,化学制药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 宏源药业 | 40.85% | 20.25% | 6.0分 |
| 2 | 多瑞医药 | 21.08% | 13.33% | 6.3分 |
| 3 | 新诺威 | 19.75% | -7.04% | 6.0分 |
| 4 | 亚虹医药 | 17.69% | 4.54% | 6.0分 |
| 5 | 苑东生物 | 14.79% | 6.21% | 6.9分 |
| 6 | 奥锐特 | 11.19% | 4.90% | 6.7分 |
| 8 | 微芯生物 | 8.54% | 1.74% | 6.1分 |
| 10 | 泰恩康 | 6.97% | 0.98% | 5.9分 |
| 12 | 力生制药 | 5.90% | 2.70% | 5.9分 |
| 14 | 海创药业 | 4.06% | -4.25% | 4.5分 |
| 16 | 新和成 | 3.07% | 2.07% | 6.6分 |
| 18 | 奥翔药业 | 2.16% | 3.66% | 6.0分 |
| 20 | 上海谊众 | 1.60% | 0.45% | 6.0分 |
| 22 | 国邦医药 | 1.27% | 6.57% | 6.5分 |
| 24 | 富祥药业 | 1.14% | -0.53% | 5.6分 |
| 26 | 益方生物 | 0.93% | -8.90% | 4.2分 |
| 28 | - | 0.51% | -2.55% | 分 |
| 30 | 普洛药业 | 0.06% | -2.28% | 5.7分 |
| 32 | 富士莱 | -0.34% | -2.20% | 5.5分 |
| 34 | 莱美药业 | -0.77% | -0.77% | 5.5分 |
| 36 | 盟科药业 | -0.82% | -0.66% | 5.7分 |
| 38 | 舒泰神 | -0.98% | 0.26% | 5.8分 |
| 40 | 纳微科技 | -1.00% | -0.46% | 6.0分 |
| 42 | 贝达药业 | -1.23% | -1.41% | 5.5分 |
| 44 | 兴齐眼药 | -1.43% | 2.24% | 6.1分 |
| 46 | 广生堂 | -1.62% | -0.45% | 4.6分 |
| 48 | 复旦张江 | -1.78% | 0.24% | 5.4分 |
| 50 | 仙琚制药 | -1.85% | -0.66% | 5.1分 |
| 52 | *ST三圣 | -1.95% | -4.03% | 4.6分 |
| 54 | 复星医药 | -2.07% | -2.29% | 4.5分 |
| 56 | 翰宇药业 | -2.24% | -4.33% | 4.8分 |
| 58 | 恒瑞医药 | -2.30% | -2.71% | 5.6分 |
| 60 | 千红制药 | -2.60% | -1.26% | 4.9分 |
| 62 | 仟源医药 | -2.69% | 0.40% | 5.6分 |
| 64 | 华润双鹤 | -3.18% | -0.92% | 4.8分 |
| 66 | 河化股份 | -3.35% | -4.12% | 5.5分 |
| 68 | 福元医药 | -3.42% | -1.88% | 6.1分 |
| 70 | 海辰药业 | -3.53% | -3.24% | 4.4分 |
| 72 | 通化金马 | -3.68% | -2.69% | 5.1分 |
| 74 | 福安药业 | -4.11% | -2.85% | 3.7分 |
| 76 | 德展健康 | -4.24% | -3.52% | 4.7分 |
| 78 | 司太立 | -4.47% | -1.67% | 5.6分 |
| 80 | 威尔药业 | -4.55% | 0.00% | 6.3分 |
| 82 | 誉衡药业 | -4.66% | -2.23% | 5.2分 |
| 84 | 能特科技 | -4.86% | 1.22% | 5.8分 |
| 86 | 常山药业 | -5.16% | -2.10% | 4.3分 |
| 88 | - | -5.41% | -3.90% | 分 |
| 90 | 宣泰医药 | -5.46% | -3.00% | 5.3分 |
| 92 | 新天地 | -5.53% | -0.84% | 5.6分 |
| 94 | 永安药业 | -5.57% | -1.39% | 4.8分 |
| 96 | ST人福 | -5.73% | -4.93% | 4.9分 |
| 98 | 海森药业 | -5.87% | -0.18% | 5.3分 |
| 100 | 华北制药 | -5.95% | -1.78% | 5.1分 |
| 102 | ST天圣 | -6.00% | -0.41% | 4.8分 |
| 104 | 山河药辅 | -6.50% | -0.96% | 4.7分 |
| 106 | - | -6.79% | -4.88% | 分 |
| 108 | 汇宇制药 | -6.91% | -1.82% | 4.8分 |
| 110 | 亿帆医药 | -7.00% | 0.34% | 5.5分 |
| 112 | 同和药业 | -7.17% | -3.35% | 4.3分 |
| 114 | 哈药股份 | -7.26% | -2.54% | 4.3分 |
| 116 | - | -7.35% | -3.49% | 分 |
| 118 | 津药药业 | -7.67% | -2.39% | 5.3分 |
| 120 | 卫信康 | -7.80% | -3.49% | 5.3分 |
| 122 | 赛托生物 | -8.49% | -0.80% | 5.0分 |
| 124 | 鲁抗医药 | -8.87% | -1.42% | 4.9分 |
| 126 | 罗欣药业 | -8.92% | -3.03% | 4.7分 |
| 128 | 赛分科技 | -9.08% | -1.99% | 5.3分 |
| 130 | 悦康药业 | -9.56% | -4.64% | 5.5分 |
| 132 | 灵康药业 | -10.24% | -2.15% | 5.2分 |
| 134 | 百利天恒 | -10.67% | -5.53% | 4.3分 |
| 136 | 尔康制药 | -11.43% | -3.40% | 4.8分 |
| 138 | 海南海药 | -12.05% | -13.65% | 5.7分 |
| 140 | 新华制药 | -12.19% | -2.47% | 4.6分 |
| 142 | 昂利康 | -13.00% | -1.03% | 6.4分 |
| 144 | 科伦药业 | -13.68% | -4.27% | 4.3分 |
| 146 | 哈三联 | -14.31% | -3.34% | 4.1分 |
| 148 | 金石亚药 | -15.39% | -4.64% | 4.6分 |
| 150 | 金城医药 | -15.87% | -1.41% | 4.4分 |
| 152 | 北大医药 | -16.98% | -3.63% | 4.7分 |
| 154 | 亨迪药业 | -18.15% | -2.24% | 4.4分 |
| 156 | 广济药业 | -26.85% | -2.90% | 5.1分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 32/217 ， 96/217。
[{"date":"2025-09-30","value":"8.60","vol":"1.51"},{"date":"2025-06-30","value":"6.16","vol":"1.23"},{"date":"2025-03-31","value":"3.77","vol":"-0.14"},{"date":"2024-12-31","value":"11.45","vol":"19.62"},{"date":"2024-09-30","value":"8.51","vol":"4.62"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
8.60 | 6.16 | 3.77 | 11.45 | 8.51 |
| 行业(%) | 1.51 | 1.23 | -0.14 | 19.62 | 4.62 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"37.49","vol":"49.36"},{"date":"2025-06-30","value":"39.82","vol":"49.33"},{"date":"2025-03-31","value":"43.40","vol":"49.14"},{"date":"2024-12-31","value":"42.33","vol":"50.78"},{"date":"2024-09-30","value":"40.05","vol":"50.61"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
37.49 | 39.82 | 43.40 | 42.33 | 40.05 |
| 行业(%) | 49.36 | 49.33 | 49.14 | 50.78 | 50.61 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 90/217 ， 56/217。
[{"date":"2025-09-30","value":"-5.87","vol":"142.98"},{"date":"2025-06-30","value":"-1.87","vol":"79.25"},{"date":"2025-03-31","value":"0.28","vol":"-0.67"},{"date":"2024-12-31","value":"20.29","vol":"18.07"},{"date":"2024-09-30","value":"21.04","vol":"45.94"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-5.87 | -1.87 | 0.28 | 20.29 | 21.04 |
| 行业(%) | 142.98 | 79.25 | -0.67 | 18.07 | 45.94 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"9.83","vol":"-3.26"},{"date":"2025-06-30","value":"113.52","vol":"58.57"},{"date":"2025-03-31","value":"273.08","vol":"-11.22"},{"date":"2024-12-31","value":"170.11","vol":"-22.02"},{"date":"2024-09-30","value":"181.96","vol":"-34.66"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
9.83 | 113.52 | 273.08 | 170.11 | 181.96 |
| 行业(%) | -3.26 | 58.57 | -11.22 | -22.02 | -34.66 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 22/217 ， 52/217。
[{"date":"2025-09-30","value":"0.48","vol":"0.31"},{"date":"2025-06-30","value":"0.31","vol":"0.21"},{"date":"2025-03-31","value":"0.16","vol":"0.10"},{"date":"2024-12-31","value":"0.71","vol":"0.43"},{"date":"2024-09-30","value":"0.54","vol":"0.33"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.48 | 0.31 | 0.16 | 0.71 | 0.54 |
| 行业(次) | 0.31 | 0.21 | 0.10 | 0.43 | 0.33 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"2.03","vol":"1.94"},{"date":"2025-06-30","value":"1.20","vol":"1.30"},{"date":"2025-03-31","value":"0.61","vol":"0.66"},{"date":"2024-12-31","value":"2.61","vol":"3.19"},{"date":"2024-09-30","value":"2.16","vol":"2.12"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
2.03 | 1.20 | 0.61 | 2.61 | 2.16 |
| 行业(次) | 1.94 | 1.30 | 0.66 | 3.19 | 2.12 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"29.10","vol":"4.43"},{"date":"2025-06-30","value":"23.86","vol":"2.74"},{"date":"2025-03-31","value":"13.52","vol":"-26.98"},{"date":"2024-12-31","value":"23.48","vol":"-373.99"},{"date":"2024-09-30","value":"17.83","vol":"-9.47"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 29.10 | 23.86 | 13.52 | 23.48 | 17.83 |
| 行业 | 4.43 | 2.74 | -26.98 | -373.99 | -9.47 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.54","vol":"1.73"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.95","vol":"2.00"},{"date":"2024-09-30","value":"","vol":"0.00"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.54 | - | 0.95 | - |
| 行业 | 0.00 | 1.73 | 0.00 | 2.00 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 60/217 ， 85/217。
[{"date":"2025-09-30","value":"2.79","vol":"3.50"},{"date":"2025-06-30","value":"2.98","vol":"3.69"},{"date":"2025-03-31","value":"2.85","vol":"3.61"},{"date":"2024-12-31","value":"2.56","vol":"3.36"},{"date":"2024-09-30","value":"2.61","vol":"3.67"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
2.79 | 2.98 | 2.85 | 2.56 | 2.61 |
| 行业 | 3.50 | 3.69 | 3.61 | 3.36 | 3.67 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"1.95","vol":"2.75"},{"date":"2025-06-30","value":"2.00","vol":"2.90"},{"date":"2025-03-31","value":"1.91","vol":"2.83"},{"date":"2024-12-31","value":"1.67","vol":"2.65"},{"date":"2024-09-30","value":"1.70","vol":"2.93"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
1.95 | 2.00 | 1.91 | 1.67 | 1.70 |
| 行业 | 2.75 | 2.90 | 2.83 | 2.65 | 2.93 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 100/217 ， 104/217。
[{"date":"2025-09-30","value":"20.69","vol":"33.63"},{"date":"2025-06-30","value":"19.80","vol":"33.66"},{"date":"2025-03-31","value":"19.51","vol":"33.90"},{"date":"2024-12-31","value":"21.22","vol":"34.07"},{"date":"2024-09-30","value":"21.00","vol":"32.87"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
20.69 | 19.80 | 19.51 | 21.22 | 21.00 |
| 行业(%) | 33.63 | 33.66 | 33.90 | 34.07 | 32.87 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.26","vol":"0.94"},{"date":"2025-06-30","value":"0.25","vol":"0.88"},{"date":"2025-03-31","value":"0.25","vol":"1.47"},{"date":"2024-12-31","value":"0.27","vol":"0.84"},{"date":"2024-09-30","value":"0.27","vol":"0.73"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.26 | 0.25 | 0.25 | 0.27 | 0.27 |
| 行业(%) | 0.94 | 0.88 | 1.47 | 0.84 | 0.73 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"10.45","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"5.40","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"4.30","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"11.61","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"10.58","blueLineValue":"1.10","type":"YC"}]